Purchase Order 75N91025P00062
Award Date
12/29/24
Potential Completion Date
12/28/25
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Roche Diagnostics Corporation for a service agreement to provide Ventana Benchmark Ultra Immunostainers. The contract has a ceiling value of $15,649.32 and a period of performance ending on March 24, 2026. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a $15,649.28 firm-fixed-price purchase order contract for a service agreement for the Ventana Benchmark Ultra Immunostainer, awarded by the National Cancer Institute to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract has an ultimate completion date of January 27, 2026. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have...
This is a $15,649.32 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The service agreement, which has no set-aside designation, covers the supply of laboratory instruments, reagents, test kits, and associated products and services through December 2025. Roche Diagnostics, a manufacturer of in vitro diagnostics, holds several Indefinite Delivery Vehicles and Blanket...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical equipment. The contract, valued at $79,779.95, is for the supply of Ventana/Roche reagents, antibodies, and disposables to support bone marrow biopsies and testing in the NIH Clinical Center's Hematology/Histology laboratory. This non-competitive award was made under simplified acquisition...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of lab supplies, including reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra Immunostainers. The $10,470.37 firm-fixed price Delivery Order was awarded on January 31, 2018 by the National Cancer Institute, with a completion date of February 28, 2018. The contract is not set aside. Roche Diagnostics is a manufacturer and distributor of in vitro...
This is a delivery order awarded by the National Cancer Institute to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra immunostainers. The firm fixed-price contract has a ceiling value of $17,786.27 and a period of performance ending on October 30, 2017. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $15,649 purchase order to Roche Diagnostics Corporation for a service agreement for the Ventana Benchmark Ultra Immunostainer. The contract has a period of performance from December 29, 2023 through December 28, 2024 and utilizes a firm fixed price pricing structure. Roche Diagnostics Corporation will provide immunostaining services at its Rockville, Maryland facility to support the...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The $8,028.69 contract provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. Roche Diagnostics has been awarded multiple federal contracts and subcontracts to supply medical and surgical equipment or supplies to agencies including the Department of...
This is a Firm Fixed Price delivery order contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $26,365.32 contract is for the provision of unspecified products and services, with a period of performance ending on April 14, 2016. This award is associated with a larger Indefinite Delivery Contract or Blanket Purchase Agreement held...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation for $15,445.60. The contract, which does not have a set-aside designation, is for the delivery of DABMAP KIT medical supplies. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products and services, has a history of...